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From the Editor 
 
The Value of Value-based Purchasing  
 
Many of our readers are no doubt aware of recent national newspaper headlines 
trumpeting “Bribing Hospitals to do Better,”1 “Employers to Pay Bonuses to Good 
Doctors,”2 and related stories. Astute readers of the medical literature have probably 
seen terms like “Bridges to Excellence”3 and “Rewarding Results”4 representing a 
clever blend of public and private efforts to extend the early gains of value-based 
purchasing. Even foreign nations like the United Kingdom have transformed their 
delivery system to reflect an unprecedented nationwide payment-for-performance 
initiative.5 What exactly do these headlines, national programs and overseas 
harbingers mean? Because value-based purchasing is such a broad, complex and 
controversial topic, I will limit the discussion here to a brief review of the research 
evidence, an update on recent progress, and a concentration on the future prospects 
and challenges inherent in such a system. 
 
First, some definitions – value-based purchasing, pay-for-performance or quality-
based purchasing are related concepts. It is clear that dramatic deficiencies in the 
quality of care delivered in the United States have been widely documented.6 
Indeed, aspects of this dilemma have been discussed in this space before.7 For our 
purposes, value-based purchasing is defined as “payment or reputational strategies 
aimed at providers that individual employers, employer coalitions or government 
programs could plausibly adopt to stimulate the improvement of quality in 
healthcare.”8 There appear to be different types of value-based purchasing extant in 
the marketplace, including programs with funds going from the government to 
hospitals, employers to health plans, and even health plans to hospitals and 
individual physicians. We simply don’t have space to evaluate all aspects of this 
fascinating recent development, but current evidence suggests that nearly a hundred 
individual performance-based purchasing programs have been documented with 
varying degrees of success and heterogeneous designs.9
The research evidence underlying value-based purchasing has recently been 
thoroughly reviewed by the Agency for Healthcare Research and Quality (AHRQ) in 
their report entitled, Strategies to Support Quality-based Purchasing: A Review of 
the Evidence.8 In the executive summary accompanying this comprehensive AHRQ 
report, the researchers note that because quality-based purchasing is in its infancy, 
their first objective was to develop a conceptual model of how these strategies could 
be used to create incentives for providers to improve care. The second objective was 
to identify all the published, peer-reviewed, randomized, controlled trials of quality-
based purchasing and to summarize what was known about their relative 
effectiveness. Finally, they sought to determine whether these outcome reports 
convey meaningful information or are too influenced by chance events to be useful. 
Indeed, a broad undertaking by whatever measure! 
 
The AHRQ researchers concluded that there is some evidence that both payment and 
reputational incentives can work but “to date there is little unequivocal data on which 
to base quality-based purchasing strategy selection.”8 In other words, despite the 
broad spectrum appeal and the logic behind paying more for better performers, the 
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early returns are decidedly mixed. I believe Steinberg was right when he said, “The 
challenge, therefore, is not to demonstrate that there already is a business case for 
quality improvement in healthcare, rather it is to establish new incentives that will 
create such a case.”10 
What of recent progress around the nation given the somewhat shaky research 
foundation just alluded to? Value-based purchasing has taken on an urgency in the 
marketplace not seen previously, due in no small part to an acceleration in the 
overall costs of healthcare, most especially the drug and hospital components. Again, 
a detailed discussion of all of the various models would be burdensome. Let me 
concentrate, then, on some recent research from our own Department of Health 
Policy. 
 
From a review that our team conducted of the published literature on value-based 
purchasing, six key strategies used by the purchaser community emerged.11 By 
focusing on the purchaser community, we can attempt to better understand the 
concept of value-based purchasing. The six strategies include: 1) collecting 
information and data on the quality of care provided by health plans and providers, 
2) selective contracting with high quality plans or providers, 3) partnering with plans 
or providers to improve quality, 4) promoting so-called Six Sigma quality in industry-
based models for minimizing errors and waste, 5) educating consumers on the 
many aspects of quality, and 6) rewarding or penalizing providers through a mixture 
of financial incentives or disincentives. Our work (based on a nationwide survey of 
purchasers in addition to the literature review) has contributed to the national 
conversation about the appropriate mixture of tools and techniques to accomplish 
value-based purchasing. 
 
Given the somewhat flimsy research basis and our assessment of the market place, 
what are some of the current and future challenges facing those involved in value-
based purchasing?  Here is where the story gets very interesting! Among the many 
challenges ahead for both purchasers and physicians include aspects of the following 
six challenges. First, “efforts to motivate doctors will have minimal effect unless the 
purchasers or insurers promoting incentive programs represent a substantial 
proportion of a physician’s practice or unless different purchasers and insurers in 
the same geographic area coordinate programs.”12 Simply put, we need to have 
enough skin in the game to make it worth our while to effect dramatic structural 
changes in what we do every day. 
 
The second challenge is in the design and implementation of these programs and 
getting the right mix of criteria for quality.  We could quibble endlessly about which 
measures are appropriate given the scores of research validated indicators now 
readily available in the marketplace. 
 
The third challenge involves the possibility that we may “unfairly penalize physicians 
caring for patients who are at a socioeconomic disadvantage and may motivate the 
physicians to reduce the number of patients for whom they provide care.”  Epstein12 
worries that rewards for quality could therefore help make the rich richer and the 
poor poorer. 
 
The fourth challenge involves the different mindset by what we mean when we say 
“a healthy purchaser.” Generally, a healthy company relates to a healthy financial 
position or so-called bottom line. Some of our leading researchers believe that a 
healthy company of the future may take on a different context relating more to 
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measurable health indices of the employers.13 Perhaps, a new partnership-based 
healthcare strategy is necessary for employers integrating health into the very 
culture of the business and encouraging and enabling thoughtful use of resources for 
the future. 
 
The fifth challenge is the perceived risk that we may be creating a two-class 
healthcare system. Physicians achieving the highest scores could become an elite 
class that charges more for their services. This may drive up overall costs and limit 
access for patients unable to pay the price. Also, in this two-class health system, is 
the concern about what society ought to do with those physicians or provider groups 
with consistently lower quality scores. Should we mandate remedial continuing 
medical education, changes in recertification or the actual credentialing process at 
hospitals and other systems? 
 
The sixth challenge is one of the cost and reliability of the quality measurement 
process itself. Without a widespread adoption of computerized medical records and 
their linkage back to legacy systems, we may not be able to effect broad-based 
adoption of value-based purchasing. For example, using an estimate of $30 
to $50 to abstract a chart by hand and an average of 50 charts per physician, annual 
data collection costs in the absence of an electronic medical record could easily 
amount to $2,500 per physician. In a metropolitan area like Philadelphia, total 
collection costs for the data alone could run easily to the millions of dollars. 
 
Given the aforementioned six challenges, is all lost then and should we abandon 
value-based purchasing pilot projects across the country? Certainly not! In my view, 
value-based purchasing represents a watershed in the quality measurement and 
improvement movement in our nation. I am confident of our ability to create 
research proven valid and reliable measures that will help us guide reimbursement 
decision making. Physician leadership in this process will be crucial to help us avoid 
some of the treacherous currents flowing around the aforementioned challenges. 
 
In that spirit, I am very proud of Jefferson Medical College and, particularly, the 
Department of Health Policy. Our early work with the Commonwealth Fund in New 
York City and our Issue Brief, How Does Quality Enter into Healthcare Purchasing 
Decisions,11 has been cited as one of the most important healthcare projects 
emanating from the Commonwealth Fund in the last two years. In addition, with our 
colleagues at the National Business Coalition on Health in Washington, D.C., and the 
Healthcare 21 Business Coalition in Knoxville, Tennessee, we have launched a 
nationwide program entitled, “The College for Advanced Management of Health 
Benefits.” The college was created to help employee benefit managers meet 
the growing challenges of providing high quality health benefits and managing rising 
benefit costs. According to our marketing brochure,14 the college offers “a practical 
intensive program that focuses on benefits purchasing techniques and skills that 
emphasize improving the value, quality cost ratio, and effectiveness of healthcare 
services purchased on behalf of employees.” In a nutshell, we are bringing to bear 
our research knowledge into a focused hands-on training program for the actual 
purchasers of medical care. 
 
We have a new book in the works to be published later this year entitled, Closing the 
Quality Chasm, published by Jones and Bartlett. This book will summarize many 
aspects of our work on value-based purchasing and provide the reader with one-stop 
shopping about these and related quality of care issues. Finally, the focus of our 11th 
Annual Summer Seminar on July 15, 2005, will be on value-based purchasing.  
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No doubt, there are many skeptics among our readers regarding the value of value-
based purchasing. After all, the research evidence is muddied and physician 
autonomy, once again, appears to be on the chopping block. I, for one, am confident 
that our own work coupled with many of our colleagues around the nation and 
those directly involved in programmatic development will convincingly demonstrate 
to the skeptics that getting paid more for doing a better job is an exciting and fruitful 
public policy we can all collective embrace. As usual, I am interested in your views 
and you can reach me at my e-mail address david.nash@jefferson.edu. 
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